从需治疗伤害人数的角度看待托法替布引发带状疱疹的风险。 - Suppr

Suppr

超能文献

Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.

作者信息

Caldera Freddy, Hayney Mary S, Cross Raymond K

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine & Public Health.

School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin.

出版信息

Inflamm Bowel Dis. 2019 May 4;25(6):955-957. doi: 10.1093/ibd/izy387.

DOI:10.1093/ibd/izy387

PMID:30605536

Abstract

摘要

相似文献

Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.

Inflamm Bowel Dis. 2019 May 4;25(6):955-957. doi: 10.1093/ibd/izy387.

Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.

Inflamm Bowel Dis. 2018 Sep 15;24(10):2258-2265. doi: 10.1093/ibd/izy131.

Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention.

Inflamm Bowel Dis. 2018 Sep 15;24(10):2173-2182. doi: 10.1093/ibd/izy150.

Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.

Gastroenterology. 2020 May;158(6):1554-1573.e12. doi: 10.1053/j.gastro.2020.01.001. Epub 2020 Jan 9.

Herpes zoster as a cause of atypical chronic ulcerations associated with tofacitinib.

Dermatol Online J. 2018 Jan 15;24(1):13030/qt3v77g2zg.

Comparison of cardiovascular, cancer and herpes zoster risk of tofacitinib versus etanercept: single-centre observational study.

Rheumatology (Oxford). 2022 Aug 30;61(9):e267-e269. doi: 10.1093/rheumatology/keac226.

Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis.

Ann Rheum Dis. 2016 Oct;75(10):1843-7. doi: 10.1136/annrheumdis-2016-209131. Epub 2016 Apr 25.

Elderly-Onset Varicella Pneumonia in a Patient With Rheumatoid Arthritis Treated With Tofacitinib.

Arthritis Rheumatol. 2018 Aug;70(8):1233. doi: 10.1002/art.40518. Epub 2018 Jul 2.

Risk for Herpes Zoster in Tofacitinib-Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids.

Arthritis Care Res (Hoboken). 2019 Sep;71(9):1249-1254. doi: 10.1002/acr.23769. Epub 2019 Jul 29.

[Relevance of involvement of tofacitinib in T cell subsets to clinical courses and adverse events in patients with rheumatoid arthritis].

Nihon Rinsho Meneki Gakkai Kaishi. 2015;38(6):443-7. doi: 10.2177/jsci.38.443.

引用本文的文献

Vaccination strategies for Korean patients with inflammatory bowel disease.

Korean J Intern Med. 2022 Sep;37(5):920-930. doi: 10.3904/kjim.2022.149. Epub 2022 Aug 8.

Health Maintenance for Adult Patients with Inflammatory Bowel Disease.

Curr Treat Options Gastroenterol. 2021;19(4):583-596. doi: 10.1007/s11938-021-00364-9. Epub 2021 Nov 22.

Vaccination of Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.

Gastroenterol Hepatol (N Y). 2021 Jan;17(1):18-30.

Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel Disease.

J Crohns Colitis. 2020 Aug 1;14(Supplement_2):S761-S766. doi: 10.1093/ecco-jcc/jjaa003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.

作者信息

Caldera Freddy, Hayney Mary S, Cross Raymond K

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine & Public Health.

School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin.

出版信息

Inflamm Bowel Dis. 2019 May 4;25(6):955-957. doi: 10.1093/ibd/izy387.

DOI:10.1093/ibd/izy387

PMID:30605536

Abstract

摘要

相似文献

Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.

Inflamm Bowel Dis. 2019 May 4;25(6):955-957. doi: 10.1093/ibd/izy387.

Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.

Inflamm Bowel Dis. 2018 Sep 15;24(10):2258-2265. doi: 10.1093/ibd/izy131.

Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention.

Inflamm Bowel Dis. 2018 Sep 15;24(10):2173-2182. doi: 10.1093/ibd/izy150.

Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.

Gastroenterology. 2020 May;158(6):1554-1573.e12. doi: 10.1053/j.gastro.2020.01.001. Epub 2020 Jan 9.

Herpes zoster as a cause of atypical chronic ulcerations associated with tofacitinib.

Dermatol Online J. 2018 Jan 15;24(1):13030/qt3v77g2zg.

Comparison of cardiovascular, cancer and herpes zoster risk of tofacitinib versus etanercept: single-centre observational study.

Rheumatology (Oxford). 2022 Aug 30;61(9):e267-e269. doi: 10.1093/rheumatology/keac226.

Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis.

Ann Rheum Dis. 2016 Oct;75(10):1843-7. doi: 10.1136/annrheumdis-2016-209131. Epub 2016 Apr 25.

Elderly-Onset Varicella Pneumonia in a Patient With Rheumatoid Arthritis Treated With Tofacitinib.

Arthritis Rheumatol. 2018 Aug;70(8):1233. doi: 10.1002/art.40518. Epub 2018 Jul 2.

Risk for Herpes Zoster in Tofacitinib-Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids.

Arthritis Care Res (Hoboken). 2019 Sep;71(9):1249-1254. doi: 10.1002/acr.23769. Epub 2019 Jul 29.

[Relevance of involvement of tofacitinib in T cell subsets to clinical courses and adverse events in patients with rheumatoid arthritis].

Nihon Rinsho Meneki Gakkai Kaishi. 2015;38(6):443-7. doi: 10.2177/jsci.38.443.

引用本文的文献

Vaccination strategies for Korean patients with inflammatory bowel disease.

Korean J Intern Med. 2022 Sep;37(5):920-930. doi: 10.3904/kjim.2022.149. Epub 2022 Aug 8.

Health Maintenance for Adult Patients with Inflammatory Bowel Disease.

Curr Treat Options Gastroenterol. 2021;19(4):583-596. doi: 10.1007/s11938-021-00364-9. Epub 2021 Nov 22.

Vaccination of Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.

Gastroenterol Hepatol (N Y). 2021 Jan;17(1):18-30.

Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel Disease.

J Crohns Colitis. 2020 Aug 1;14(Supplement_2):S761-S766. doi: 10.1093/ecco-jcc/jjaa003.